%0 Journal Article
%T Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach
%A Pine, Sharon R.
%A Ryan, Bríd M.
%J Translational Lung Cancer Research
%D 2018
%B 2018
%9 
%! Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach
%K 
%X In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is that most patients present with advanced-stage disease, a time during which systemic therapies are unlikely to be curative.
%U https://tlcr.amegroups.org/article/view/23934
%P S265-S269
%@ 2226-4477